{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:17:50Z","timestamp":1794521870422,"version":"4.9.1"},"reference-count":60,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>(1) Background: The importance of total eosinophil count in peripheral blood (EOS) as a type 2 inflammation marker is known to be fundamental in asthma, chronic sinusitis, and vasculitis. In cancer, despite their questionable antiproliferative effect, their role remains unclear. Our purpose was to describe the relationship between baseline blood EOS and overall survival (OS) in pancreatic ductal adenocarcinoma (PDAC) patients. (2) Methods: We retrospectively analyzed data from 137 adult patients who underwent surgical treatment for pancreatic ductal adenocarcinoma (PDAC) between the years 2012 and 2019. Patients with no recent history of systemic steroid use and without intraoperative metastases were included. Patients were categorized into two groups based on EOS (\u22650.1 G\/l and &lt;0.1 G\/l). Survival outcomes were analyzed using Cox proportional hazards regression models. (3) Results: According to EOS and PDAC stage, median OS values were as follows: in stage I\u2013III, EOS \u2265 0.1 G\/l group: 14.5 months, in stage I\u2013III, EOS &lt; 0.1 G\/l group: 8.0 months, in stage IV, EOS \u2265 0.1 G\/l group: 7.0 months, and in stage IV, EOS &lt; 0.1 G\/l group: 5.0 months. EOS &lt; 0.1 G\/l (vs. \u22650.1 G\/l) was an independent prognostic factor for OS in both the uni- and multivariate Cox regression, respectively (HR = 1.48, p = 0.035 and HR = 1.57, p = 0.021). (4) Conclusions: Peripheral eosinophilia seems to be a potential independent prognostic factor. Further studies are necessary to confirm this hypothesis, since our findings suggest that type 2 inflammation may be the factor directly or indirectly lengthening the survival of patients with PDAC.<\/jats:p>","DOI":"10.3390\/biomedicines12112596","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T08:09:28Z","timestamp":1731485368000},"page":"2596","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-6745","authenticated-orcid":false,"given":"Wojciech","family":"Ciesielski","sequence":"first","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Kupry\u015b-Lipi\u0144ska","sequence":"additional","affiliation":[{"name":"Internal Medicine, Asthma and Allergy Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kumor-Kisielewska","sequence":"additional","affiliation":[{"name":"Department of Pneumology and Allergy, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"Grz\u0105siak","sequence":"additional","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Borodacz","sequence":"additional","affiliation":[{"name":"Students\u2019 Scientific Association in General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-4456","authenticated-orcid":false,"given":"Sebastian","family":"Nied\u017awiecki","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Hogendorf","sequence":"additional","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Durczy\u0144ski","sequence":"additional","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Strzelczyk","sequence":"additional","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-1831","authenticated-orcid":false,"given":"Alicja","family":"Majos","sequence":"additional","affiliation":[{"name":"General and Transplant Surgery Department, Medical University of \u0141\u00f3d\u017a, 90-419 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic Cancer: A Review of Current Treatment and Novel Therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Investig. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Weyhe, D., Obonyo, D., Uslar, V.N., Stricker, I., and Tannapfel, A. (2021). Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248633"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3748\/wjg.v21.i9.2807","article-title":"Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2147\/OTT.S154162","article-title":"Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: A comprehensive meta-analysis of 17 cohort studies","volume":"11","author":"Zhou","year":"2018","journal-title":"Onco Targets Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajh.23916","article-title":"Association of the blood eosinophil count with hematological malignancies and mortality","volume":"90","author":"Andersen","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Majos, A., Sewerynek, E., Grz\u0105siak, O., Ciesielski, W., Hogendorf, P., Ho\u0142y\u0144ski, J., Strzelczyk, J., and Durczy\u0144ski, A. (2022). FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010077"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Szmiel, A., Majos, A., Ciesielski, W., Kumor, A., Strzelczyk, J., Szwedziak, K., Hogendorf, P., and Durczy\u0144ski, A. (2022). Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour-Pilot Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061573"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-1095-4_21","article-title":"Experimental Modeling of Eosinophil-Associated Diseases","volume":"2241","author":"Manohar","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fettrelet, T., Gigon, L., Karaulov, A., Yousefi, S., and Simon, H.U. (2021). The Enigma of Eosinophil Degranulation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137091"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00281-021-00856-x","article-title":"Intestinal eosinophils, homeostasis and response to bacterial intrusion","volume":"43","author":"Gurtner","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Rodrigo-Mu\u00f1oz, J.M., Gil-Mart\u00ednez, M., Sastre, B., and Del Pozo, V. (2021). Emerging Evidence for Pleiotropism of Eosinophils. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22137075"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1146\/annurev-immunol-093019-125918","article-title":"Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies","volume":"39","author":"Jacobsen","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.178.7.4222","article-title":"Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance","volume":"178","author":"Simson","year":"2007","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12094-019-02113-y","article-title":"Unveiling the mechanisms of immune evasion in pancreatic cancer: May it be a systemic inflammation responsible for dismal survival?","volume":"22","author":"Holub","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Moreira, A., Erdmann, M., Uslu, U., Vass, V., Schuler, G., and Schuler-Thurner, B. (2020). Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030210"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.21037\/jtd-20-3525","article-title":"Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy","volume":"13","author":"Alves","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2217\/imt-2021-0149","article-title":"Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer","volume":"14","author":"Ghebeh","year":"2022","journal-title":"Immunotherapy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/0284186X.2014.887857","article-title":"Eosinophilia in routine blood samples as a biomarker for solid tumor development\u2014A study based on the Copenhagen Primary Care Differential Count (CopDiff) Database","volume":"53","author":"Andersen","year":"2014","journal-title":"Acta Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MPA.0000000000001731","article-title":"The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer","volume":"50","author":"Ohkuma","year":"2021","journal-title":"Pancreas"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/JAA.S227170","article-title":"Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma","volume":"12","author":"FitzGerald","year":"2020","journal-title":"J. Asthma Allergy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e256235","DOI":"10.1136\/bcr-2023-256235","article-title":"Hypereosinophilia as a presenting sign of advanced pancreatic adenocarcinoma: A rare, severe presentation","volume":"16","author":"Cohen","year":"2023","journal-title":"BMJ Case Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-2094-9-11","article-title":"Eosinophils in glioblastoma biology","volume":"9","author":"Curran","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hu, G., Wang, S., Zhong, K., Xu, F., Huang, L., Chen, W., and Cheng, P. (2020). Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: A meta-analysis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06966-3"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/apm.12809","article-title":"Eosinophilia is a favorable prognostic marker for oral cavity and lip squamous cell carcinoma","volume":"126","author":"Peurala","year":"2018","journal-title":"APMIS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2559.2002.01437.x","article-title":"Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas","volume":"41","author":"Dorta","year":"2002","journal-title":"Histopathology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9610(05)80102-3","article-title":"Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx","volume":"168","author":"Thompson","year":"1994","journal-title":"Am. J. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<436::AID-CNCR3>3.0.CO;2-I","article-title":"Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma","volume":"77","author":"Leighton","year":"1996","journal-title":"Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/modpathol.2014.104","article-title":"Peritumoral eosinophils predict recurrence in colorectal cancer","volume":"28","author":"Harbaum","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S","article-title":"Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma","volume":"88","author":"Sanz","year":"2000","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I","article-title":"Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue","volume":"189","author":"Nielsen","year":"1999","journal-title":"J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2016.42","article-title":"Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women\u2019s health study","volume":"29","author":"Prizment","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.3390\/ijms15069718","article-title":"Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma","volume":"15","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_35","first-page":"1419","article-title":"Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma","volume":"26","author":"Ishibashi","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ejh.12987","article-title":"An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome","volume":"100","author":"Hollander","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/1097-0142(19860915)58:6<1321::AID-CNCR2820580623>3.0.CO;2-O","article-title":"Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer","volume":"58","author":"Iwasaki","year":"1986","journal-title":"Cancer"},{"key":"ref_38","first-page":"82","article-title":"Tumor-associated tissue eosinophilia of penile cancer","volume":"9","author":"Ono","year":"2002","journal-title":"Int. J. Urol. Off. J. Jpn. Urol. Assoc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jcp.46.11.1016","article-title":"Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix","volume":"46","author":"Bethwaite","year":"1993","journal-title":"J. Clin. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1066896909333778","article-title":"Tissue eosinophilia and its association with tumoral invasion of oral cancer","volume":"17","author":"Tjioe","year":"2009","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0090-4295(92)90524-Z","article-title":"Tumor-associated tissue inflammatory reaction and eosinophilia in primary superficial bladder cancer","volume":"40","author":"Flamm","year":"1992","journal-title":"Urology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/lary.27413","article-title":"Clinical implications of tumor-associated tissue eosinophilia in tongue squamous cell carcinoma","volume":"129","author":"Paz","year":"2018","journal-title":"Laryngoscope"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00130404-200505000-00008","article-title":"Tissue eosinophilic infiltration: A useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia","volume":"11","author":"Alrawi","year":"2005","journal-title":"Cancer J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.otohns.2005.01.041","article-title":"Prognostic significance of stromal eosinophilic infiltration in cancer of the larynx","volume":"132","author":"Ercan","year":"2005","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1288\/00005537-199504000-00014","article-title":"Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma. Veterans administration laryngeal cooperative study group","volume":"105","author":"Sassler","year":"1995","journal-title":"Laryngoscope"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02893504","article-title":"Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin\u2019s lymphoma","volume":"13","author":"Keresztes","year":"2007","journal-title":"Pathol. Oncol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood.V95.4.1207.004k34_1207_1213","article-title":"Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin\u2019s disease, allowing for known prognostic factors","volume":"95","author":"Seth","year":"2000","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0046-8177(96)90216-6","article-title":"Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response","volume":"27","author":"Hogendoorn","year":"1996","journal-title":"Hum. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"FSO608","DOI":"10.2144\/fsoa-2020-0070","article-title":"A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy","volume":"6","author":"Krishnan","year":"2020","journal-title":"Future Sci. OA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00325481.2017.1246345","article-title":"Eosinophilia as the presenting sign in pancreatic cancer: An extremely rare occurrence","volume":"129","author":"Ibrahim","year":"2017","journal-title":"Postgrad. Med."},{"key":"ref_51","first-page":"1061","article-title":"Severe eosinophilia associated with a malignant islet cell tumour","volume":"140","author":"Haldane","year":"1989","journal-title":"CMAJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1600-0609.1987.tb01457.x","article-title":"Pancreatic carcinoma associated with marked eosinophilia: A case report","volume":"39","author":"Hirata","year":"1987","journal-title":"Eur. J. Haematol."},{"key":"ref_53","first-page":"1373","article-title":"A case of severe eosinophilia in a case of cancer of the head of the pancreas","volume":"34","author":"Checinska","year":"1964","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Abu-Shawer, O., Abu-Shawer, M., Shurman, A., Lattouf, A., Haimour, A., Hamdan, O., Mansour, R., Altamimi, T., and Al-Hussaini, M. (2020). The clinical value of peripheral immune cell counts in pancreatic cancer. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0232043"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and Activity of Anti\u2013PD-L1 Antibody in Patients with Advanced Cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of Pembrolizumab in Patients with Noncolorectal High Microsatellite Instability\/Mismatch Repair\u2013Deficient Cancer: Results From the Phase II KEYNOTE-158 Study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial","volume":"5","author":"Oh","year":"2019","journal-title":"JAMA Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/annonc\/mdu205","article-title":"A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer","volume":"25","author":"Aglietta","year":"2014","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S1195","DOI":"10.1016\/j.annonc.2020.08.2300","article-title":"LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)","volume":"31","author":"Renouf","year":"2020","journal-title":"Ann. Oncol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/11\/2596\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:31:33Z","timestamp":1760113893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/12\/11\/2596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":60,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["biomedicines12112596"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines12112596","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}